| ₹ crore | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue | 806 | 650 | +24.0% |
| EBITDA | 126 | 75.4 | +67.1% |
| EBITDA margin | 15.6% | 11.6% | +4.0 pts |
| Profit before tax | 61.4 | 11.2 | +446.5% |
| Net profit | 38.6 | 6.0 | +546.1% |
| EPS | ₹0.33 | ₹0.06 | +450.0% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 |
|---|
| 17,784 | — | |
| 1,349 | 1,393 | |
| 283 | 283 | |
| 16,718 | — | |
| 2,988 | 2,711 | |
| 459 | 358 | |
| 15.4% | 13.2% | |
| 171 | 88.4 | |
| 160 | 113 | |
| 5.4% | 4.2% | |
| ₹1.39 | ₹0.98 | |
| — | 395 | |
| — | −238 | |
| 157 | 157 | |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|
| Market Capitalization | — | 17,783.7 | |
| - Cash, Equiv & ST Investments | 1,393.1 | 1,348.7 | |
| + Total Debt | 282.9 | 282.9 | |
| Enterprise Value | — | 16,717.9 | |
| Revenue | 2,710.6 | 2,987.9 | |
| EBITDA | 358.5 | 459.3 | |
| Margin % | 13.23 | 15.37 | |
| EBIT | 88.4 | 171.0 | |
| Net Income | 112.5 | 159.9 | |
| Margin % | 4.15 | 5.35 | |
| EPS, Adj (current shares) | 0.98 | 1.39 | |
| Cash from Operations | 395.4 | — | |
| Capital Expenditures | -238.4 | — | |
| Free Cash Flow | 157.0 | 157.0 | |
Prices at the previous close · figures from the company's filings with NSE
Pine Labs (NSE: PINELABS) had a market capitalisation of ₹17,883 crore at the previous close (₹154.87 a share), a PE ratio of 111.8 on the last four quarters' profit and a price-to-book ratio of 2.97. In FY26 its consolidated net profit was ₹113 crore on revenue of ₹2,711 crore; in Q2 FY27 (July–September 2026) it was ₹38.6 crore, up 546.1% year on year. Its debt-to-equity ratio was 0.03 on 30 September 2026.
Pine Labs' PE ratio is 111.8 at the previous close (₹154.87 a share): a market capitalisation of ₹17,883 crore divided by consolidated net profit of ₹160 crore over the last four quarters (Q3 FY26 to Q2 FY27). On FY26 net profit (₹113 crore) it is 158.9.
Pine Labs' price-to-book (PB) ratio is 2.97 at the previous close: a market capitalisation of ₹17,883 crore divided by shareholders' equity (book value) of ₹6,019 crore on 30 September 2026. That is a book value of ₹52.13 per share against a share price of ₹154.87.
Pine Labs' net worth — shareholders' equity in its consolidated balance sheet — was ₹6,019 crore on 30 September 2026, up 62.2% from ₹3,711 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹17,883 crore at the previous close.
Pine Labs' market capitalisation was ₹17,883 crore at the previous close: 115.47 crore shares at ₹154.87 each.
No. Pine Labs had borrowings of ₹183 crore on 30 September 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.03. Its cash and current investments were ₹8,540 crore, so it held net cash of ₹8,357 crore.
Pine Labs' basic earnings per share (EPS) were ₹1.05 in FY26.
Pine Labs' debt-to-equity ratio was 0.03 on 30 September 2026: borrowings of ₹183 crore against total equity of ₹6,019 crore. A year earlier, on 30 September 2025, it was 0.20.
Pine Labs' book value per share was ₹52.13 on 30 September 2026: shareholders' equity of ₹6,019 crore divided by the 115.47 crore shares in issue. The share price at the previous close was ₹154.87.
Pine Labs has no promoter group: on 30 September 2026 promoters held 0% of its shares, according to the shareholding pattern filed with NSE. Foreign portfolio investors held 13.18% and domestic institutions 29.58%.
On 30 September 2026, Pine Labs' shares were held by foreign portfolio investors (FII/FPI) 13.18%, domestic institutions (DII) 29.58% (including mutual funds at 26.69%) and retail and other non-institutional investors 57.24%.
In FY26, Pine Labs generated ₹395 crore of cash from operations and spent ₹238 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹157 crore.
Pine Labs' latest results are for Q2 FY27 (July–September 2026), filed on 29 October 2026: consolidated net profit ₹38.6 crore, up 546.1% from ₹6 crore in Q2 FY26; revenue from operations ₹806 crore, up 24.0% year on year.
In FY26 (April 2025–March 2026), Pine Labs' consolidated net profit was ₹113 crore, on revenue from operations of ₹2,711 crore.
Pine Labs has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.
In FY26, Pine Labs earned net profit of ₹113 crore on revenue of ₹2,711 crore, against ₹553 crore on ₹8,437 crore for Paytm. Pine Labs' operating margin was 3.3% (Paytm −0.8%).
From Pine Labs' own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.